31 results  1 of 2 

1 Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes
Chang Ho Ahn, Tae Jung Oh, Se Hee Min, Young Min Cho
Endocrinol Metab.2023;38(1):1-9.   Published online 2023 February 13     DOI: http://dx.doi.org/10.3803/EnM.2023.103
      
2 Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond
Adie Viljoen, Stephen C. Bain
Endocrinol Metab.2023;38(1):25-33.   Published online 2023 February 6     DOI: http://dx.doi.org/10.3803/EnM.2022.1642
      
3 DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice
Youjin Kim, Si Woo Lee, Hyejin Wang, Ryeong-Hyeon Kim, Hyun Ki Park, Hangkyu Lee, Eun Seok Kang
Diabetes Metab J.2022;46(2):337-348.   Published online 2022 January 21     DOI: http://dx.doi.org/10.4093/dmj.2021.0056
      
4 Recent Updates on Glucagon-Like Peptide 1 Receptor Agonist
Hae Jin Kim
J Korean Diabetes.2021;22(2):126-133.   Published online 2021 June 30     DOI: http://dx.doi.org/10.4093/jkd.2021.22.2.126
      
5 Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials
Shinje Moon, Jibeom Lee, Hye Soo Chung, Yoon Jung Kim, Jae Myung Yu, Sung Hoon Yu, Chang-Myung Oh
Endocrinol Metab.2021;36(3):647-660.   Published online 2021 June 18     DOI: http://dx.doi.org/10.3803/EnM.2020.934
      
6 Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim
Endocrinol Metab.2021;36(1):157-170.   Published online 2021 February 24     DOI: http://dx.doi.org/10.3803/EnM.2020.781
      
7 Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists
Hun Jee Choe, Young Min Cho
Endocrinol Metab.2021;36(1):22-29.   Published online 2021 February 24     DOI: http://dx.doi.org/10.3803/EnM.2021.102
      
8 Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
Jae Hyun Bae, Hyung Jin Choi, Kang Ik Kevin Cho, Lee Kyung Kim, Jun Soo Kwon, Young Min Cho
Diabetes Metab J.2020;44(2):248-259.   Published online 2019 November 4     DOI: http://dx.doi.org/10.4093/dmj.2019.0018
      
9 Saxenda® Frenzy: Opinions of an Endocrine and Metabolism Specialist
Sungrae Kim
J Korean Diabetes.2019;20(2):63-66.   Published online 2019 June 30     DOI: http://dx.doi.org/10.4093/jkd.2019.20.2.63
      
10 Premeal Consumption of a Protein-Enriched, Dietary Fiber-Fortified Bar Decreases Total Energy Intake in Healthy Individuals
Chang Ho Ahn, Jae Hyun Bae, Young Min Cho
Diabetes Metab J.2019;43(6):879-892.   Published online 2019 June 25     DOI: http://dx.doi.org/10.4093/dmj.2018.0202
      
11 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
Soyeon Yoo, Eun-Jin Yang, Gwanpyo Koh
Diabetes Metab J.2019;43(4):495-503.   Published online 2019 February 20     DOI: http://dx.doi.org/10.4093/dmj.2018.0105
      
12 Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
Hyeonhui Kim, Sungsoon Fang
Lab Anim Res.2018;34(4):140-146.   Published online 2018 December 31     DOI: http://dx.doi.org/10.5625/lar.2018.34.4.140
      
13 Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
Yu Mi Kang, Yun Kyung Cho, Jiwoo Lee, Seung Eun Lee, Woo Je Lee, Joong-Yeol Park, Ye-Jee Kim, Chang Hee Jung, Michael A. Nauck
Diabetes Metab J.2019;43(4):410-421.   Published online 2018 December 27     DOI: http://dx.doi.org/10.4093/dmj.2018.0070
      
14 Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
Yu Mi Kang, Chang Hee Jung
Endocrinol Metab.2017;32(3):316-325.   Published online 2017 September 18     DOI: http://dx.doi.org/10.3803/EnM.2017.32.3.316
   
15 Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus
Sang Ah Lee, Gwanpyo Koh, Suk Ju Cho, So-Yeon Yoo, Sang Ouk Chin
Endocrinol Metab.2016;31(3):439-445.   Published online 2016 September 26     DOI: http://dx.doi.org/10.3803/EnM.2016.31.3.439
      
16 Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Yu Mi Kang, Chang Hee Jung
Endocrinol Metab.2016;31(2):258-274.   Published online 2016 April 25     DOI: http://dx.doi.org/10.3803/EnM.2016.31.2.258
   
17 Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus
Sunghwan Suh, Mi Yeon Kim, Soo Kyoung Kim, Kyu Yeon Hur, Mi Kyoung Park, Duk Kyu Kim, Nam H. Cho, Moon-Kyu Lee
Endocrinol Metab.2016;31(1):134-141.   Published online 2016 March 16     DOI: http://dx.doi.org/10.3803/EnM.2016.31.1.134
      
18 Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion
Eun Ky Kim, Tae Jung Oh, Lee-Kyung Kim, Young Min Cho
J Korean Med Sci.2016;31(2):222-230.   Published online 2016 January 26     DOI: http://dx.doi.org/10.3346/jkms.2016.31.2.222
      
19 Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes
Hye Min Lee, Bo Sun Joo, Chang Hoon Lee, Heung Yeol Kim, Ji Hoon Ock, Young Seok Lee
J Menopausal Med.2015;21(2):93-103.   Published online 2015 August 28     DOI: http://dx.doi.org/10.6118/jmm.2015.21.2.93
      
20 Clinical Application of Glucagon-Like Peptide-1 Receptor Agonists
Se Hee Min, Young Min Cho
J Korean Diabetes.2015;16(4):252-259.   Published online 2015 January 10     DOI: http://dx.doi.org/10.4093/jkd.2015.16.4.252
   

 1 of 2